Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence by Goldmann JM et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Goldmann JM, Seplyarskiy VB, Wong WSW, Vilboux T, Neerincx PD, Bodian 
DL, Solomon BD, Veltman JA, Deeken JF, Gilissen C, Niederhuber JE. 
Germline de novo mutation clusters arise during oocyte aging in genomic 
regions with high double-strand-break incidence. 
Nature Genetics 2018,  
https://doi.org/10.1038/s41588-018-0071-6  
 
 
Copyright: 
This is the authors accepted manuscript of an article that has been published in its final form by Nature 
Publishing Group, 2018. 
 DOI link to article: 
https://doi.org/10.1038/s41588-018-0071-6  
Date deposited:   
06/03/2018 
Embargo release date: 
05 September 2018  
1 
 
Germline de novo mutation clusters arise during 1 
oocyte aging in genomic regions with increased 2 
double-strand break incidence 3 
Jakob M. Goldmann1*, Vladimir B. Seplyarskiy2,3*, Wendy S.W. Wong4*, Thierry Vilboux4, 4 
Pieter B. Neerincx5,6, Dale L. Bodian4, Benjamin D. Solomon7,8, Joris A. Veltman9,10, John F. 5 
Deeken4, Christian Gilissen9#, John E. Niederhuber4,11# 6 
 7 
1Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud 8 
University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands  9 
2Division of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, 10 
Massachusetts, USA. 11 
3Institute for Information Transmission Problems of the Russian Academy of Sciences 12 
(Kharkevich Institute), Bolshoi Karetny pereulok 19, Moscow 127994, Russia 13 
4Inova Translational Medicine Institute (ITMI), Inova Health Systems, Falls Church, VA, USA 14 
5Department of Genetics, University of Groningen, University Medical Center Groningen, 15 
Groningen, The Netherlands 16 
6Genomics Coordination Center, University of Groningen, University Medical Center 17 
Groningen, Groningen, The Netherlands 18 
7Department of Pediatrics, Inova Children’s Hospital, Inova Health System, Falls Church, VA, 19 
USA 20 
8Department of Pediatrics, Virginia Commonwealth University School of Medicine, 1201 E 21 
Marshall St, Richmond, VA, USA 22 
9Department of Human Genetics, Donders Centre for Neuroscience, Radboud University 23 
Medical Center , Geert Grooteplein 10, 6525 GA Nijmegen, the Netherlands  24 
10Institute of Genetic Medicine, International Centre for Life, Newcastle University, 25 
Newcastle upon Tyne, United Kingdom 26 
11Johns Hopkins University School of Medicine, 733 North Broadway Street, Baltimore, MD, 27 
USA  28 
 29 
*These authors contributed equally. 30 
# These authors jointly supervised this work. 31 
 32 
2 
 
To whom correspondence should be addressed: Christian.gilissen@radboudumc.nl and 33 
John.Niederhuber@inova.org 34 
  35 
3 
 
Clustering of mutations has been observed in cancer genomes as well as for germline de 36 
novo mutations (DNMs). We identified 1,796 clustered DNMs (cDNMs) within whole-37 
genome sequencing data from 1,291 parent-offspring trios to investigate their patterns and 38 
inferred a mutational mechanism. We found that the number of clusters on the maternal 39 
allele was positively correlated with maternal age and that these consist of more individual 40 
mutations with larger inter-mutational distances compared to paternal clusters. More than 41 
50% of maternal clusters were located on chromosomes 8, 9 and 16, in regions with an 42 
overall increased maternal mutation rate. Maternal clusters in these regions showed a 43 
distinct mutation signature characterized by C>G transversions. Finally, we found that 44 
maternal clusters associate with processes involving double-stranded-breaks (DSBs) such as 45 
meiotic gene conversions and de novo deletions events. This suggest accumulation of DSB-46 
induced mutations throughout oocyte aging as an underlying mechanism for maternal 47 
mutation clusters.  48 
 49 
50 
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De novo mutations (DNMs) arise spontaneously in parental gametes and result in 51 
approximately 50-100 germline mutations in their offspring1-4. As such, DNMs are both 52 
drivers of evolution as well as a common cause of sporadic disorders. The total number of 53 
DNMs is highly correlated with paternal age and, to a lesser extent, with maternal age2-4. The 54 
paternal age effect, giving rise to about one additional DNM in the offspring per year of life 55 
of the father before conception, is thought to be due to the higher number of cell divisions 56 
that spermatogonial cells of older men have undergone prior to this period5,6. The 57 
mechanisms underlying the maternal age effect, giving rise to about one additional DNM per 58 
4 years of life of the mother, are still unknown. Approximately 2-3% of all DNMs in the 59 
offspring occur in close spatial proximities (below 20kb) as clustered mutations4,7-11. These 60 
clustered DNMs (cDNMs) have a distinct nucleotide substitution spectrum with an 61 
enrichment of C>G mutations, suggesting mutational mechanisms different from 62 
unclustered DNMs4,9,10,12,13. The precise composition of the mutation spectrum also varies 63 
with the inter-mutational distances of the clusters10,14. Contrary to unclustered DNMs, no 64 
paternal bias has been observed for the number of cDNMs4,9,12. Here, we investigated 65 
cDNMs, their potential contribution to the paternal and maternal age effect on the total 66 
number of DNMs, and the possible mechanisms underlying their occurrence. 67 
Whole genomes of 1,291 parent-offspring trios from the Inova Translational Medicine 68 
Institute longitudinal childhood study cohort were sequenced using Illumina HiSeq2000 with 69 
average 40x coverage by Illumina services (La Jolla, USA; Table 1, Supplementary Table 1). 70 
This cohort represents a sample of the general population of average health giving birth at a 71 
single hospital15. After quality control, we identified 73,755 high-confidence DNMs using a 72 
random forest classifier (Online Methods, Supplementary Table 2). We defined cDNMs as 73 
DNMs within the same individual with all pair-wise inter-mutational distances smaller than 74 
20kb. In total we identified 1,796 cDNMs (2.4% of all DNMs) distributed across 799 clusters, 75 
with 2-10 mutations per cluster, of which 678 clusters (85%) consisted of exactly two 76 
mutations (Supplementary Tables 3-6). 144 cDNMs in 72 clusters were directly adjacent. By 77 
performing read-phasing, we successfully identified the parent-of-origin for 700 cDNMs 78 
(39.0% of all cDNMs) across 400 clusters (Table 1, Supplementary Table 7-8). In 98.0% 79 
(204/208) of the fully phased clusters, all cDNMs arose on the same allele, which is in line 80 
with our simulations of the false detection rate of cluster detection (Supplementary Table 81 
9). In contrast to unclustered DNMs, we did not observe an excess of cDNMs on the paternal 82 
allele (202 maternal clusters and 198 paternal clusters, chi-square goodness-of-fit p=0.84). In 83 
addition, we created a validation dataset based on four independent studies with phased 84 
DNMs from whole-genome sequencing (WGS)4,9,10,12, resulting in a total of 1,643 cDNMs 85 
across 745 clusters, with limited information on parental ages (Table 1, Supplementary 86 
Table 10). 87 
To investigate the contribution of cDNMs to the parental age effects, we used a linear 88 
regression model to correlate the age of each parent with the number of phased cDNMs in 89 
the offspring. Although the number of paternal cDNMs did not show a significant correlation 90 
with the paternal age (p=0.087), we found a highly significant correlation of maternal cDNMs 91 
with maternal age (p<10-10). This effect was similar in our replication cohort (maternal 92 
p=0.00155 and paternal p=0.319, Supplementary Figures 1,2). In the primary cohort, the 93 
cDNMs accounted for 23% (95% c.i. 7-38%) of the maternal age effect (p-value for maternal 94 
age effect of unclustered DNMs p=1.5x10-19). For the clusters where only a subset of cDNMs 95 
could be phased, we extrapolated the parent-of-origin. Based on this extrapolation, we also 96 
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observe a significant paternal age effect of a smaller amplitude than the maternal age effect 97 
(paternal effect size p=0.026/year, p=8x10-7, maternal effect size 0.041/year, p=3x10-11). 98 
While in the primary cohort, only 5% of the probands with the youngest mothers had one or 99 
more maternal cDNMs per genome, this was more than 5 times higher (risk ratio test, 100 
p=1.4x10-11; c.i. 3.0-9.4) in probands from the oldest mothers (27% having a maternal cDNM, 101 
Figure 1a). This difference was not significant for the paternal cDNMs (13% vs 19%; risk ratio 102 
test p=0.08; risk ratio 1.42; 95% c.i. 0.95-2.12). In the replication cohort, the risk ratio was 103 
3.02 for maternal cDNMS (c.i. 1.22-7.45; p=0.011, Supplementary Figure 3) and 0.60 (c.i. 104 
0.30-1.22; p=0.15) for paternal cDNMs. 105 
We found that this maternal age effect of clusters stems mostly from clusters with inter-106 
mutational distances greater than 1kb (Figures 1b,c, Supplementary Tables 11 and 12, 107 
Supplementary Figure 3). Strikingly, the maximum number of DNMs in the phased clusters 108 
of an individual correlates positively with maternal age (p<10-10, replication cohort p<10-4), 109 
but is correlated only marginally significant with paternal age (p=0.050, replication cohort 110 
p=0.408, Figure 1d,e, Supplementary Figure 3). Clusters with more than two mutations were 111 
4.2 times more likely to contain maternal cDNMs than paternal cDNMs (95% c.i. 2.5 – 7.6; 112 
p=1.7x10-7). These results show that maternal clusters contain more cDNMs with larger 113 
inter-mutational distances. 114 
We previously observed that maternal DNMs are enriched within specific genomic regions 115 
on chromosomes 8 and 164. In this study, we found that 58.4% of maternal cDNMs localize 116 
to chromosomes 8, 9 and 16 (p<10-16, replication cohort p<10-16, Chi-square test; Figure 2a, 117 
Supplementary Figures 4 and 5). This in contrast to paternal cDNMs for which the number 118 
correlates with chromosome length (R²=0.72, p=6*10-7, replication cohort R2=0.43, p=0.001). 119 
The maternal cDNMs on these three chromosomes occur specifically in regions that are also 120 
enriched for maternal unclustered DNMs (Figure 2b, Supplementary Figures 6 and 7, 121 
Supplementary Note 1) and their mutation spectrum is strongly enriched for C>G 122 
substitutions compared to other maternal cDNMs (Figure 2c,d, bootstrapping p=0.022). 123 
These observations are further supported by the patterns of clusters with more than two 124 
cDNMs, which are more likely to be on the maternal allele. These clusters are also enriched 125 
on the chromosomes 8, 9 and 16 (Chi-square test p=3x10-09), and show an excess of C>G 126 
substitutions (Chi-square test p=4.5x10-11). Taken together, this suggests a different 127 
mutational mechanism for maternal cDNMs in these regions compared to the rest of the 128 
genome. 129 
To confirm these findings, we created a dataset of (unphased) clustered SNP variants based 130 
on publically available population-based genetic data16 (Online Methods). This resulted in 131 
1,146,891 clustered SNPs (cSNPs) across 522,487 clusters (Supplementary Table 13). We 132 
found that cSNPs on chromosomes that are enriched for maternal cDNMs are enriched for 133 
C>G substitutions (bootstrapping test, see Online Methods, p<0.001, Figure 2e). To further 134 
investigate this association, we calculated a genome-wide score for C>G cSNP enrichment 135 
(Supplementary Methods) and found that the number of maternal cDNMs in a region is 136 
significantly correlated with high C>G scores (Poisson regression p<10-16 for maternal 137 
cDNMs, p=0.33 for paternal cDNMs, Supplementary Figure 8). Using this method we also 138 
identified an additional region on chromosome 2 that is enriched for maternal cDNMs 139 
(Figure 2f). This strong association between C>G scores of cSNPs with maternal cDNMs 140 
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highlights the maternal clusters’ profound contribution to population polymorphisms in 141 
these regions.  142 
The observed age-effect of maternal cDNMs suggests underlying mechanisms that are active 143 
during oocyte aging, a process that has been associated with the decreasing efficiency of 144 
double-strand break (DSB) repair17-19. We therefore hypothesized that the maternal-aging 145 
associated clusters arise via a DSB-associated mechanism and investigated the occurrence of 146 
cDNMs at regions that are associated with DSBs. As proxies for DSB sites we used (1) sites of 147 
de novo meiotic gene conversion (MGC), (2) the flanking regions of de novo CNV breakpoints 148 
in our cohort, and (3) known recombination hotspots20.  149 
We used MGC sites from Halldorsson et al.21 and found that these events co-localize with 150 
maternal cDNMs significantly more often than expected by chance (p=0.002, permutation 151 
testing, Figure 3a, Supplementary Table 14). This association is not significant for paternal 152 
MGCs with paternal cDNMs (p=0.609).  153 
In our primary cohort, we identified 45 high-quality de novo CNVs, of which 5 have a total of 154 
17 DNMs within 100kb flanking the breakpoints (Figure 3b, Supplementary Methods). 155 
Exactly 12 of these 17 DNMs are cDNMs, which constitutes a high enrichment (p = 2.58x10-156 
16, Fisher’s exact test). For 6 of these DNMs the parent-of-origin was resolved and in all cases 157 
the DNMs arose from the maternal allele (p=0.03, Fisher’s exact test). In concordance with 158 
this, all 5 CNVs are deletions of the maternal allele (Supplementary Table 15). An 159 
arrangement of several DNMs and a de novo deletion on the same allele within the same 160 
generation is very unlikely to occur by chance and suggests a single event as a common 161 
cause. In our replication cohort, we also discovered 5 de novo deletion events. Two of these 162 
CNVs have a total of 4 DNMs from the same individual within 100kb of the CNV breakpoints, 163 
and two of these are within 20kb of each other (Supplementary Figure 9), again showing an 164 
enrichment of cDNMs (p=0.002, Fisher’s exact test). Interestingly, cSNPs were significantly 165 
closer to CNV breakpoints than expected by chance (Figure 3c, Mann-Whitney test on 1% of 166 
data p<10-9), corroborating the co-segregation of CNV events and clustered mutations. 167 
Finally, we used gender specific recombination scores20 to assess whether cDNMs occur 168 
more often at regions of high recombination. We did not find a significant overlap of 169 
maternal cDNMs with regions of high maternal recombination (p=0.204 permutation testing, 170 
Figure 3d, Supplementary Table 14). Nevertheless, genomic regions with maternal cDNMs 171 
had higher sex-matched recombination scores than regions with only unclustered maternal 172 
DNMs (primary cohort p=0.019, replication cohort p=0.13) and higher than regions of 173 
paternal cDNMs (primary cohort p=0.004, replication cohort p=0.29; Supplementary Figure 174 
10). In addition, genomic regions with cSNPs have significantly higher recombination rates 175 
than genomic regions without cSNPs (p=3.91x10-49). Interestingly, our observed association 176 
of cDNMs with recombination rates is much smaller than the observed association with 177 
MGCs. This is in line with the maternal age effect of MGCs being larger compared to the 178 
maternal age effect of the crossover rate21,22. Campbell et al. found that, with increasing 179 
maternal age, recombination occurs more frequently outside of recombination hotspots23. In 180 
addition, these events were increasingly deregulated, appearing in closer proximity of each 181 
other than expected based on models of crossover interference. The fact that recombination 182 
events have shown to be mutagenic24-26 suggests that this increase in deregulated 183 
recombination events may be the underlying cause of cDNM formation. In this study, we 184 
found that that chromosomes 8, 9 and 16 are heavily enriched for maternal clusters and 185 
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strikingly these chromosomes also have the highest degree of cross-over events escaping 186 
interference23.  187 
Additionally, cDNM mutational spectra, and in particular those of maternal cDNMs, are very 188 
similar to the previously identified signature of somatic mutations caused by deficiency in 189 
homologous recombination repair of DSBs27,28 (Signature 3, Supplementary Figure 11). The 190 
proband’s parents are very unlikely to suffer from DNA repair deficiencies such as those 191 
underlying cancer mutation profiles, therefore this finding is in agreement with a key role for 192 
imperfect DSB repair after unregulated recombination in the formation of maternal 193 
mutation clusters. However, we found no statistical association between variants in genes 194 
involved in homologous recombination repair or in establishing recombination sites29-31 195 
(Supplementary Tables 16 and 17). 196 
Although the formation of clustered mutations has the potential to be highly deleterious, 197 
there seems to be selection in favor of high recombination rates in ageing oocytes32,33. It has 198 
been argued that these high recombination rates provide protection against aneuploidies33-199 
34, the risk of which increases with maternal age. Taken together, our results show that 200 
deregulated recombination is a likely cause for DNM clusters, whereas replicative errors are 201 
not a likely cause. A recent paper that studied genome-wide de novo mutations in a cohort 202 
of 1,548 Icelanders also found that clustered mutations increase faster with maternal than 203 
paternal age35. In addition, the authors observed a non-uniform distribution of these events 204 
across the genome35 corresponding with the regions that we reported here.  205 
206 
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Figure 1: Differences between maternal and paternal cDNMs (a) The fraction of probands 313 
with maternal and paternal clustered mutations (y-axis), grouped by parental age quantiles. 314 
Error bars indicate the binomial 95% confidence intervals. Labels on the lower axis indicate 315 
age ranges of the respective groups and group sizes. See Supplementary Figure 1 for graphs 316 
and regression lines. (b) The number of paternal and maternal cDNMs (y-axis) stratified by 317 
the distance to the nearest other cDNM (x-axis). (c) The size of paternal and maternal age 318 
effect of clusters with at least one phased cDNM (y-axis) by inter-mutational distance (x-319 
axis). Whiskers indicate the 95% confidence interval. (d) Age of fathers at conception and (e) 320 
age of the mothers at conception (y-axis) by the number of mutations in the offspring’s 321 
largest mutation cluster (x-axis). We considered only clusters where at least one cDNM is on 322 
the allele from the respective parent (paternal allele for d and maternal allele for e). 323 
Numbers indicate the size of each group. Boxplot compartments: box: interquartile range; 324 
line: median; whiskers: extreme values <1.5 × interquartile ranges from box borders). 325 
Figure 2: Patterns of cDNMs across the chromosomes. (a) The proportion of phased cDNMs 326 
per chromosome. Error bars indicate the binomial 95% confidence intervals. (b) Overview of 327 
chromosome 16 region enriched for maternal cluster mutations. X-axis and ideogram 328 
indicate chromosomal position. The red and blue histograms indicate the number of 329 
maternal cDNMs and paternal cDNMs identified in this study, respectively. The pale red and 330 
pale blue histograms indicate the number of maternal and paternal unclustered DNMs 331 
(ucDNMs). The lowest track indicates normalized cSNP C>G score, which is predictive for 332 
maternal DNMs. (c) The nucleotide substitution spectrum of maternal and paternal clusters 333 
and unclustered DNMs. The star indicates a significant difference assessed by bootstrapping 334 
(Online Methods). Error bars indicate the binomial 95% confidence intervals. (d) The 335 
nucleotide substitution spectrum of cDNMs by location. Error bars indicate the binomial 95% 336 
confidence intervals. (e) The nucleotide substitution spectrum of polymorphism-derived 337 
clustered mutation by location. The star indicates a significant difference assessed by 338 
bootstrapping. Error bars indicate the binomial 95% confidence intervals. (f) Region with 339 
increased maternal mutation rate on chromosome 2 (region displayed chr2:1-340 
100,000,000bp; region with maternal cDNMs chr2:40,000,000-60,000,000).  341 
Figure 3: cDNMs and sites likely affected by DSBs. (a) Z-scores of expected and observed 342 
overlaps of cDNM clusters in our cohort and sex-matched meiotic gene conversion in 343 
another cohort21. Diamonds: observed values, boxplot compartments: box: interquartile 344 
range; line: median; whiskers: extreme values <1.5 × interquartile ranges from box borders. 345 
(b) DNMs detected close to sites of de novo CNVs. Data of DNMs is listed in Supplementary 346 
Table 15. (c) cSNP density close to CNV breakpoints (Online Methods). (d) Z-scores of 347 
expected and observed overlap cDNM clusters and sex-matched recombination hotspots. 348 
Symbols and boxplots as in (a). 349 
 350 
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Main Tables 352 
Table 1: Overview of cohorts 353 
Cohort 
 
Total number Paternal number Maternal number 
Primary cohort Probands 1,291  
 DNMs 73,755 20,196 5,547 
 cDNMs 1,796 323 377 
 Clusters 799 110 (+88) 94 (+108) 
   
Replication cohort Probands 1,557  
 DNMs 74,395 9,466 2,796 
 cDNMs 1,643 133 195 
 Clusters 745 40 (+49) 67 (+46) 
     
Numbers of probands, DNMs, cDNMs and clusters of the cohorts used in this study. The 354 
numbers in brackets indicate clusters where not all cDNMs could be phased for the 355 
respective parent. 356 
357 
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Online Methods 358 
Cohort 359 
The cohort used in this study is from Inova Translational Medicine Institute’s 360 
Longitudinal Childhood Genome Study (previously referred to as the First 1,000 Days of 361 
Life and Beyond study), which represents a population cohort in good general health4,15. 362 
The study was conducted by the Inova Translational Medicine Institute and approved by 363 
both the Inova and Western Institutional Review Boards (study 20120204). Parents and 364 
the newborns were recruited at Inova Fairfax Hospital between 2012 and 2014. A 365 
summary of participants' ages is given in Supplementary Table 1. 366 
Whole genome sequencing 367 
Sample preparation, processing and whole-genome sequencing (WGS) have been 368 
previously described4,15. Briefly, DNA was extracted from peripheral blood obtained 369 
from each family member. Whole genome sequencing using paired-end 100bp reads 370 
(median fragment length is 375) at an average 40X coverage was performed by Illumina 371 
Services (San Diego, CA). The sequenced reads were aligned to the hg19 human 372 
reference genome by the ISAAC aligner36 with the Illumina Whole Human Genome 373 
Sequencing Service Informatics Pipeline version 2.01 - 2.03. 374 
To systematically analyze the data quality of all sequencing reactions, a principal 375 
component analysis on scaled summary statistics was performed (Supplementary 376 
Figure 12, Supplementary Table 18). The first principal component is highly 377 
correlated to average sequencing coverage; a group of outlying points refers to a group 378 
of sequencing reactions with average genome coverage above 70x. The second principal 379 
component is associated with the date of sequencing and the version of the software 380 
used for analysis, respectively. The third principal component is related to the estimated 381 
ancestries of the sequenced individuals. 382 
DNM calling and quality control 383 
Callable regions of each sample were determined by CallableLoci in GATK version 3.1. 384 
The number of callable bases by batch is shown in Supplementary Figure 13. The 385 
batch number does not significantly influence the number of DNMs called 386 
(Supplementary Table 19). Joint calling using HaplotypeCaller, PhaseByTransmission 387 
and ReadBackPhasing in GATK version 3.1 were performed on each of the 1,315 trios in 388 
the canonical autosomes37. The putative de novo mutations were generated from taking 389 
PASS filter calls with heterozygous in the proband and homozygous reference in both 390 
parents in the PhaseByTransmission results in each trio. We have previously analyzed 391 
816 trios4, of which, 65 trios were also sequenced by the Illumina services with pipeline 392 
version 2.0.0-2.0.1, and are not part of this cohort. These 65 trios sequenced by Illumina 393 
have gone through the same pipeline to generate a set of putative DNMs. We defined the 394 
positive set as those putative DNMs that overlap with previous identified DNMs 395 
identified using Complete Genomics (CG) technology (2,670), as well as those that were 396 
validated by Sanger sequencing (34), the total number in the true positive set is 2,704. 397 
The negative set consists of 50 random putative DNMs in each of the 65 trios that are not 398 
in the previously identified set by CG (50*65=3,250), as well as 4 false positive sites 399 
identified by Sanger, the total number of negative sites is 3,254. We note that some of 400 
the sites in the negative set are true positives but the number is likely to be low. The test 401 
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set which consists of the positive and negative sets was split by 90:10 ratio into training 402 
set and test set. The R libraries randomForest version 4.6.10 and caret version 6.0.52 403 
were used to train the random forest classifier. The OOB estimate of error rate on 404 
training set is 1.77% and the error rate in the test set is 2.18%. The features used in the 405 
classifier and their relative importances are shown in Supplementary Table 20. The 406 
confusion matrix for the test set is shown in Supplementary Table 21. 407 
In order to minimize the bias due to mapping errors and coverage differences, we 408 
further filtered the predicted DNMs by (1) callable regions in the cohort: A site is in the 409 
callable region if at least 90% of the samples has the PASS status by GATK CallableLoci37, 410 
(2) good mappability regions, where mappable is defined according to the CRG 100mer 411 
(file wgEncodeCrgMapabilityAlign100mer.bw from UCSC Table Browser) being equal to 412 
138, sites also called by the Illumina Isaac Small Variant Caller, and sites with FS 413 
(FisherStrand test score) >=20, and sites with exceptionally high or low PL values 414 
(Supplementary Table 22). An overview of the filtering procedure is given in 415 
Supplementary Table 2. 416 
In the initial sequencing cohort, there were 12 monozygotic twin pairs, 29 dizygotic twin 417 
pairs and a family of three trizygotic siblings. In order to assess the consistency in de 418 
novo calling, we investigated the concordance percentages of monozygotic and dizygotic 419 
families (Supplementary Table 23 and Supplementary Table 24). DNM calls in 420 
monozygotic twins are on average 95% concordant, the dizygotic average concordance 421 
is 0.1%. This is similar to concordance ratios observed previously4. 422 
We removed 1 trio with an exceptional high number of DNM calls, 8 trios with a large 423 
chromosomal anomaly in either the proband or one of the parents and removed 424 
(arbitrarily) one of the monozygotic twins  in each set. After performing simple multiple 425 
linear regression, 3 samples have a significant Bonferroni p-value for studentized 426 
residuals (Bonferroni corrected p<0.05) and are removed from the cohort, resulting in 427 
1,291 trios (Supplementary Table 2). We investigated the effect of average genome 428 
coverage on the filtered data. The results are shown in Supplementary Figure 14. 429 
The method for determining the parent-of-origin of DNMs with Illumina WGS trio data 430 
was previously described3,4. Briefly, GATK PhaseByTransmission was used to assign 431 
parent-of-origin to informative heterozygous SNPs in the proband, GATK 432 
ReadBackPhasing was used to link DNMs to these informative SNPs. If contradictory 433 
markers were linked to the same DNM, it would not be assigned a parent-of-origin. 434 
Overall, 227 of the 25,970 filtered DNMs are linked to contradictory markers (0.87%).  435 
Clustered DNMs 436 
We defined cDNMs as DNMs on the same chromosome of the same individual within 437 
20kb of each other. In order to estimate the chance of two DNMs being closer than 20kb 438 
on the same chromosome, we simulated 70,000 mutations at random positions within 439 
the callable and mappable genome. The randomized positions were given sample IDs as 440 
in the set of observed DNMs and the distances were calculated. We found that the false 441 
discovery rate of cluster detection is 0.0375 at a threshold of 20kb (Supplementary 442 
Table 9). Statistics on the number of cDNMs per cluster are given in Supplementary 443 
Table 3. 444 
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For analyses on clusters we extrapolated the parent-of-origin by considering all cDNM to 445 
originate from the same allele. 446 
Sanger validation 447 
We performed Sanger validation on 163 clustered DNM sites on the proband and his or 448 
her parents, of which 62 are on chromosomes 8, 9 and 16 (Supplementary Table 25A).  449 
Overall, 91.3% of the DNMs are validated, 92.7% on chromosomes 8,9 and 16 vs. 90.4% 450 
on other chromosomes. The number of sites validated in each pipeline version is 451 
proportional to the number of trios sequenced in each pipeline (Supplementary Table 452 
25B). There is no significant difference in the proportion of sites validated in each 453 
pipeline (P = 0.92, Fisher’s exact test). No evidence of the mutations was found at any 454 
site in the parents. All of the invalidated sites were due to lack of evidence in the 455 
proband. 456 
Clustered polymorphism variants 457 
We use polymorphism data from the 1000 Genomes Project Consortium16. We only 458 
considered non-singleton variants with below 1% derived allele frequency, using the 459 
ancestral variant determined by The 1000 Genomes Project Consortium. Clusters were 460 
defined as two or more SNPs at distances between 10-1000 nucleotides from each other, 461 
such that all the genotypes carrying the derived allele for one of the SNPs also carry the 462 
derived allele for any other SNP within the cluster. We show that cSNP spectra are 463 
similar to cDNM spectra: enriched by C>G mutations and depleted by CpG>TpG 464 
mutations, compared to unclustered DNMs. We restricted ourselves to distances 465 
between cSNPs shorter than 1000 nucleotides, because of two reasons. First, the 466 
probability of recombination scales with the distance between SNP positions and thus 467 
longer clusters are more frequently disrupted. Second, the probability to observe two 468 
independent mutations on the same haplotype would be ~20 fold higher in 1-20 kb 469 
range than in 0-1 kb range. In contrast we observe 806 cDNMs in 0-1 kb range and 990 470 
cDNMs in 1-20 kb range. Therefore, we expect a higher noise to signal ratio for larger 471 
distances. In line with this, the spectra of larger clusters are progressively less similar to 472 
cDNMs (Supplementary Figure 15). For analyzing the density of cSNPs around CNV 473 
breakpoints, we calculated the distances between cSNPs and CNVs on the chromosomes 474 
of each individual. We only considered cSNPs flanking CNVs, but not within its body. 475 
These distances were compared to the distances between cSNPs and the CNVs on the 476 
same chromosome of a random other individual. 477 
Statistical assessment of the maternal age effect 478 
For analyzing the parental age effects on both the number of clusters as well as the 479 
number of cDNMs, linear models were fitted using the R statistical environment version 480 
3.3.3 with standard settings. The reported p-values reflect the difference from zero of 481 
the respective age effect.  482 
Extrapolations of DNM phasing were done by assigning a cluster’s unphased DNMs the 483 
same allele as the phased ones. In order to correct for the false detection rate of 3.75% 484 
(Supplementary Table 9), we sampled 1,000 subsets of 100%-3.75%= 96.25% of 485 
cDNMs and calculated the age effects on all of them. We report the median effect size 486 
and the median p-value. 487 
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For comparing proband groups’ risks for having DNM clusters we used risk ratio 488 
statistics as implemented in the R package “epitools”. For assessing the enrichment of 489 
C>G substitutions on chromosomes 8, 9 and 16, we re-sampled the chromosome 490 
annotation 1,000 times and compared the difference of the fractions of C>G mutations 491 
on the special chromosomes and the remaining autosomes to the observed value. 492 
Statistical assessment of nucleotide substitution profiles 493 
The significance of differences between nucleotide substitution profiles was assessed by 494 
bootstrapping: We resampled the grouping variable 1,000 times and compared the 495 
resulting random groups to the observed groups. For assessing C>G enrichment we 496 
calculated p-values by counting the number of random groups where the difference in 497 
C>G fractions between the groups is equal to or larger than in the observed set and 498 
dividing by the number of samplings. 499 
Statistical assessment of DSB proxy regions overlap 500 
For calculating distributions on the expected number of overlaps between DNM clusters 501 
and DSB proxy regions we used permutation testing as implemented in the R library 502 
RegioneR39. DNM cluster regions were defined as the positions of cDNMs and the space 503 
between them. Recombination hotspots were defined as genomic sites with a 504 
recombination-score above 1020. Meiotic gene conversions were filtered for non-505 
crossover gene conversions only detected in the chip dataset21. In absence of knowledge 506 
about the exact boundaries of the conversion streak and confronted with the majority of 507 
meiotic gene conversions being observed only in one SNP, we defined the positions of 508 
meiotic gene conversions as the distance between the two SNPs adjacent to the SNPs 509 
affected by conversion. The cluster regions were randomized 500 times to genomic 510 
positions where at least 1000 base pairs were within the callable and mergable subset of 511 
the genome. For every randomization round the number of cluster positions overlapping 512 
DSB proxy regions was compared to the observed number of overlaps. For the 513 
calculation of z-scores of an overlap count the mean number of overlaps was subtracted 514 
before division by the standard deviation of the number of overlaps. 515 
De novo CNVs 516 
In the primary cohort, we called de novo CNVs using both coverage-based method 517 
FREEC40 and read-pair based method Manta41. We also calculated window based 518 
normalized coverage with “goleft indexcov”. For each proband, we called CNVs using the 519 
default options in FREEC with the proband as the case and one of the parents as control. 520 
We then required the CNVs subtracted from each parent to have 90% reciprocal overlap, 521 
with copy number equals 1 or 3, both parents have the mean normalized coverage 522 
between 0.85 and 1.15 in the region, the proband have mean normalized coverage 523 
smaller than 0.85 or greater than 1.15 in the region, with length greater or equal to 524 
10kb. We performed joint calling for each trio with Manta using default options. We then 525 
filter for SV type being DEL or DUP, proband with GT equals to 0/1 and both parents 526 
with GT equal to 0/0, proband’s PR and SR for ALT allele >=3 and the proportion of PR 527 
and SR for ALT >=0.2, parents’ proportion of PR and SR for ALT <=0.05. 528 
In the complete genomics data in the replication cohort, we required the de novo CNV to 529 
be called by both coverage-based and read-based methods. For the coverage-based 530 
method, we first subtracted CNVs in the proband from one of the parents using the 531 
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cnvSegmentsDiploidBeta files, and then we intersect the two putative de novo CNV files 532 
subtracted from each parent, with 90% overlap, and size >9999. For the read-based 533 
method, we subtracted highConfidenceSvEventsBeta file from the proband from 534 
allSvEventsBeta file from each of the parents, and intersected the two subtracted files 535 
requiring 90% overlap. The final list of de novo CNVs is generated by intersecting the 536 
coverage-based and read-based files from the same proband, requiring 90% overlap. 537 
Bedtools 2.22.0 was used to carry out region subtractions and intersections42.  538 
Mutation signatures 539 
A large set of mutational signatures is known from cancer studies27, some of which are 540 
well annotated with mutational influences. To fit the patterns of our DNMs to these 541 
signatures we used an algorithm similar to the one described in43: a non-negative least-542 
squares algorithm finds the mixture of known signatures that describes best the 543 
observed pattern. In order to get an indication of the robustness of the fitted mixture of 544 
signatures, a bootstrapping analysis was done. The mutations of a group were 545 
resampled 1,000 times with replacement and the standard deviation as well as the 95% 546 
confidence intervals of each fitted signature were calculated. 547 
Single variant association study of parents genotype in BRCA1, BRCA2 and 548 
PRDM9 with number of phased cDNMs in the proband 549 
The small variants in the autosomes were merged using “agg” with Illumina genome VCF 550 
files using default parameters. No sample had a call rate <90%. In this analysis, only 551 
those variants in BRCA1, BRCA2, PRDM9, and marker rs2914276, with call rate >90%, no 552 
significant deviation from Hardy-Weinberg equilibrium (P>0.001), and with minor allele 553 
frequency >0.005 were included.  No LD pruning was performed. If a parent has more 554 
than 1 offspring in the cohort (twins or siblings), only one of the sibling’s number of 555 
phased cDNMs is kept as the phenotype for the respective parent. The association 556 
analysis was performed with Plink v.1.90b44 with additive model on paternal genotypes 557 
with paternal number of cDNMs, using paternal age at conception, and father’s first 3 558 
PCs as covariates;  and on maternal genotypes with maternal number of cDNMs, using 559 
maternal age at conception, and mother’s first 3 PCs as covariates , respectively.  The 560 
association study included 1,247 fathers and 1,247 mothers. No variant reached 561 
significance (P<0.05) after Bonferroni correction. 562 
 563 
Data availability 564 
De novo mutation calls used in this manuscript will be available in dbGaP, by the 565 
accession code phs001522.v1.p1. 566 
Code availability 567 
Code available upon request. 568 
 569 
570 
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